Promises and Pitfalls of Genetic Screening for Rare Thyroid Cancer

Early surgery may benefit patients shown to be at risk for medullary thyroid cancer through genetic screening program, but overall merit of such gene testing remains debatable, say editorialists.

Related Keywords

Danville ,Pennsylvania ,United States ,White River Junction ,Vermont ,Nicolasc Purdy ,Louise Davies ,Peter Angelos ,Mycode Community Health Initiative Genomic Screening ,Geisinger Medical Center ,University Of Alabama At Birmingham ,Counseling Program ,Kaiser Permanente Center ,Geisinger Department Of Otolaryngology ,University Of Chicago ,Department Of Veterans Affairs Medical Center ,Health Research ,Requiring Aggressive ,Mycode Community Health Initiative ,Genomic Screening ,Medscape Medical ,Natural History ,Veterans Affairs Medical Center ,Thyroid Cancer ,Thyroid Carcinoma ,Ancer Of The Thyroid ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Thyroid Disorder ,Genomics ,Genomic Medicine ,Edicine Genomic ,Malignant Head And Neck Neoplasm ,Breast Cancer ,Alignant Breast Neoplasm ,Medullary Thyroid Carcinoma ,Edullary Carcinoma Of The Thyroid ,Papillary Carcinoma Of The Thyroid ,Papillary Thyroid Carcinoma ,Cancer ,Alignant Neoplasia ,Barcino ,